QA: Carisma Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2025_Carisma_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 23,825,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 6,633,000
4 LiabilitiesCurrent 16,055,000
5 LiabilitiesNoncurrent 1,042,000
6 remainder_Liabilities 41,270,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,234,218
9 ResearchAndDevelopmentExpense 59,904,956
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 20,210,923
13 remainder_ComprehensiveNetIncome 14,943
  yvar yval
0 Assets 30,458,000
1 Liabilities 58,367,000
2 Expenses 80,139,174
3 Revenues 0
4 StockholdersEquity -27,909,000
5 NetIncome -59,928,251
6 ComprehensiveNetIncome -59,920,780
7 BaseVar 94,595,020
8 EconomicCapitalRatiobeforeLimitedLiability -2.72
9 EconomicCapitalRatio 0.781

Edgar->Model Mapping

Feature Distribution

Change over Time